NCT00112866 2017-06-14
Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 2 Terminated
Clinical Trials
5 trialsNCT01122888 2015-04-28
Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00082875 2013-06-05
Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00006222 2013-06-03
EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00089388 2013-01-24
Cilengitide in Treating Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 2 Terminated